Half-year report · HY
6197.TEDINET S100X2BQ
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥70.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥137.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥68.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥3.5bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥3.7bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥3.5bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥6.7bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.5bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥3.8bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥3.5bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.4bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.4bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥1.9bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥68.9bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥70.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥70.5bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥45.0bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥47.4bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥23.9bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥22.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥21.5bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.0bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥11.0bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.3bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.1bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥381m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥113m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥347m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥720m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥3.9bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥7.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.9bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥25.6 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.94 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.99 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 34.7% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.5% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥22m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥22m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥3m |
| Children Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥5.3bn |
| Children Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥5.3bn |
| Children Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥39m |
| Elderly Care Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥28.1bn |
| Elderly Care Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥28.1bn |
| Elderly Care Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥1.5bn |
| Medical Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥36.6bn |
| Medical Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥36.6bn |
| Medical Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥2.1bn |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥70.0bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥70.0bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥3.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥23m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥23m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥4m |
| Children Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥5.0bn |
| Children Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥5.0bn |
| Children Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥78m |
| Elderly Care Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥27.8bn |
| Elderly Care Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥27.8bn |
| Elderly Care Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| Medical Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥35.5bn |
| Medical Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥35.5bn |
| Medical Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2.3bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥68.4bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥68.4bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥3.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 475
| Item | Context | Value | Unit |
|---|---|---|---|
| Liabilities | Prior1YearInstant | 47412000000 | JPY |
| Liabilities | InterimInstant | 44970000000 | JPY |
| Capital stock | Prior1YearInstant | 686000000 | JPY |
| Capital stock | InterimInstant | 686000000 | JPY |
| Capital surplus | Prior1YearInstant | 5575000000 | JPY |
| Capital surplus | InterimInstant | 5563000000 | JPY |
| Retained earnings | Prior1YearInstant | 17745000000 | JPY |
| Retained earnings | InterimInstant | 19183000000 | JPY |
| Treasury stock | Prior1YearInstant | -1444000000 | JPY |
| Treasury stock | InterimInstant | -1640000000 | JPY |
| Shareholders equity | Prior1YearInstant | 22563000000 | JPY |
| Shareholders equity | InterimInstant | 23793000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 115000000 | JPY |
| Remeasurements of defined benefit plans | InterimInstant | 105000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 115000000 | JPY |
| Valuation and translation adjustments | InterimInstant | 105000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 5000000 | JPY |
| Subscription rights to shares | InterimInstant | 5000000 | JPY |
| Net assets | Prior1YearInstant | 22684000000 | JPY |
| Net assets | InterimInstant | 23905000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 70097000000 | JPY |
| Liabilities and net assets | InterimInstant | 68875000000 | JPY |
| Net sales | Prior1InterimDuration | 68388000000 | JPY |
| Net sales | InterimDuration | 70033000000 | JPY |
| Cost of sales | Prior1InterimDuration | 57053000000 | JPY |
| Cost of sales | InterimDuration | 58721000000 | JPY |
| Gross profit | Prior1InterimDuration | 11335000000 | JPY |
| Gross profit | InterimDuration | 11311000000 | JPY |
| Selling general and administrative expenses | Prior1InterimDuration | 7656000000 | JPY |
| Selling general and administrative expenses | InterimDuration | 7805000000 | JPY |
| Operating income | Prior1InterimDuration | 3678000000 | JPY |
| Operating income | InterimDuration | 3506000000 | JPY |
| Subsidy income noi | Prior1InterimDuration | 43000000 | JPY |
| Subsidy income noi | InterimDuration | 88000000 | JPY |
| Other noi | Prior1InterimDuration | 42000000 | JPY |
| Other noi | InterimDuration | 117000000 | JPY |
| Non operating income | Prior1InterimDuration | 86000000 | JPY |
| Non operating income | InterimDuration | 206000000 | JPY |
| Interest expenses noe | Prior1InterimDuration | 147000000 | JPY |
| Interest expenses noe | InterimDuration | 132000000 | JPY |
| Other noe | Prior1InterimDuration | 161000000 | JPY |
| Other noe | InterimDuration | 62000000 | JPY |
| Non operating expenses | Prior1InterimDuration | 309000000 | JPY |
| Non operating expenses | InterimDuration | 194000000 | JPY |
| Ordinary income | Prior1InterimDuration | 3455000000 | JPY |
| Ordinary income | InterimDuration | 3517000000 | JPY |
| Gain on redemption of investment securities ei | Prior1InterimDuration | － | JPY |
| Gain on redemption of investment securities ei | InterimDuration | 309000000 | JPY |
| Extraordinary income | Prior1InterimDuration | － | JPY |
| Extraordinary income | InterimDuration | 309000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |